240 patients to test if SMART stents keep leg arteries open Long-Term

NCT ID NCT07338890

Not yet recruiting Disease control Sponsor: Cordis US Corp. Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study will follow 240 people who have already received a SMART stent to treat narrowing in their leg arteries (iliac, femoral, or popliteal). Researchers want to see how well the stents work over time and if they prevent major complications like amputation. The goal is to confirm the stents are safe and effective for long-term use.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: S.M.A.R.T. nitinol stent system (a mesh tube placed in the artery to keep it open)
What this could lead to: If successful, this study could confirm that these stents are a safe and effective long-term option for treating blocked leg arteries, potentially reducing the need for repeat procedures.
What could go wrong: This is a post-market observational study, not a randomized trial, so results may be less definitive. Stents carry risks like re-narrowing or blood clots, and long-term benefits are not guaranteed.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ILIAC ARTERY STENOSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ILIAC ARTERY STENOSIS POPLITEAL ARTERY STENOSIS SUPERFICIAL FEMORAL ARTERY STENOSIS

240 patients to test if SMART stents keep leg arteries open Long-Term

Summary

What this could mean

Get notified about this study

As listed by the trial registrant

Contacts and locations

Locations

More trials for these conditions